Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioNova
AddedFeb 17, 2024
UpdatedJun 18, 2026
BioNova

BioNova

Series A

BioNova, leveraging marine-derived technology, innovatively treats post-surgical wounds.

HQ
Germantown, TN, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

BioNova was founded with the mission to revolutionize wound care through innovative, marine-derived technology. The company's core vision is to enhance post-surgical recovery by leveraging natural materials for medical applications. BioNova offers a biodegradable chitosan-based dermal regeneration scaffold (DRS) called Foundation DRS Solo, which is designed to promote cellular invasion and capillary growth. This advanced wound care product is aimed at improving healing outcomes for patients in the post-surgical market.

Key figures affiliated with BioNova include researchers from the University of Memphis, where the foundational technology was developed. Notable investors and partners have supported BioNova's growth and innovation in the medical field. The company has achieved significant milestones, including the development and commercialization of its patented wound care device. BioNova's impact lies in its potential to improve patient recovery times and reduce complications associated with post-surgical wounds.

BioNova - Similar Companies

Biofisica logo

Biofisica

biofisica.com

Biowound Solutions logo

Biowound Solutions

RenovoDerm logo

RenovoDerm

Regennova logo

Regennova

regennova.com

Novoron Bioscience logo

Novoron Bioscience

novoron.com

OsteoNovus logo

OsteoNovus

osteonovus.com

Newco Wound Care logo

Newco Wound Care

BioTissue logo

BioTissue

biotissue.com

SweetBio logo

SweetBio

sweetbio.com

NovaDerm Aid logo

NovaDerm Aid

MLM Biologics logo

MLM Biologics

mlmbiologics.com

NovoThelium logo

NovoThelium

novothelium.com

Nuo Therapeutics logo

Nuo Therapeutics

nuot.com

Liventa Bioscience logo

Liventa Bioscience

NeXtGen Biologics logo

NeXtGen Biologics

BioNova - Quick Facts

Who are BioNova's competitors?

Companies similar to BioNova include Biofisica, Biowound Solutions, RenovoDerm and Regennova.

When was BioNova founded?

BioNova was founded in 2011.

Where is BioNova's headquarters located?

BioNova's headquarters is located in Germantown, TN, US.

When was BioNova's last funding round?

BioNova's most recent funding round was for $1M (USD) in May 2021.

How much has BioNova raised to-date?

As of May 25, 2021, BioNova has raised a total of $2.9M (USD).

How many employees does BioNova have?

BioNova has 6 employees as of Feb 4, 2024.

BioNova - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Wound Care
Tags
  • Biotech
  • Healthcare
  • Healthtech
  • Medical
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified